Kitov Pharma Ltd. Warrants
KTOVW
KTOVW was delisted on the 23rd of November, 2020.
1 hedge funds and large institutions have $55K invested in Kitov Pharma Ltd. Warrants in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
588% more capital invested
Capital invested by funds: $8K → $55K (+$47K)
50% less funds holding
Funds holding: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1K |
KTOVW Hedge Fund Activity: Q2 2018 in Review
1 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q2 2018, worth a combined $55K — up 588% from $8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of KTOVW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $7K sold.
- 1 institutional investor held Kitov Pharma Ltd. Warrants (KTOVW) as of Q2 2018, down from 2 in Q1 2018.
- Funds reported $55K of Kitov Pharma Ltd. Warrants stock for Q2 2018, up 588% quarter-over-quarter.
- 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q2 2018 and 2 closed out, a net change of -1 holder.
- The largest Kitov Pharma Ltd. Warrants seller in Q2 2018 was Susquehanna International Group, an estimated $7K sold.
Based on aggregated 13F filings for Q2 2018.